Clinical trial Recruiting at 1 site Interventional Ages 35 and up

Cohort study on newly diagnosed COPD in smokers

Official title: Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Run by Assistance Publique - Hôpitaux de Paris · NCT04252781 · Data updated 2026-11-12

This study is testing how well screening smokers for COPD in regular doctor visits can help identify new patients and track their health over time.

Quick facts

Study typeInterventional
Ages35 Years and up
SexAll
Enrollment300 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Créteil, Île-de-France Region)
StatusRecruiting
StartedAugust 20, 2020
Main results expectedJanuary 7, 2025
Study endsFebruary 20, 2026
Registry record updatedJanuary 9, 2025
Trial IDNCT04252781 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are smokers over the age of 35 with a significant smoking history who are actively smoking.

Probably not a fit

Patients with known COPD or those undergoing treatment for cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to systematically screen smokers for Chronic Obstructive Pulmonary Disease (COPD) using spirometry in general medicine settings. It will include 1500 smokers, with the goal of identifying 300 newly diagnosed COPD patients, equally divided by gender. The study will explore the evolution of these patients' conditions based on their initial phenotype and management strategies. By documenting the trajectories of these patients, the study seeks to provide valuable insights into the real-life management of COPD.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection and management of COPD in smokers, potentially reducing healthcare costs and improving patient outcomes.

How similar studies have gone: Other studies have shown success with systematic screening approaches for COPD, indicating potential for this study's methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Inclusion criteria of smokers with spirometry (pre-inclusion)

* Age\> 35 years
* Smoking \> 20 PA
* Active smoking (cessation \< 1 month)
* Signature of consent to participate in Phase I of the study

Inclusion criteria for patients with incidental COPD

* FEV1 / FVC \<70% of the theoretical value and / or \<LLN (Lower limit of normal)
* Signature of consent to participate in Phase II of the study

Exclusion Criteria:

* Known COPD
* Cancer being treated
* No affiliation to the social security or other social protection scheme
* Pregnant or lactating woman
* Patient deprived of liberty or under legal protection (under tutorship or curatorship

Where it's running

  • Hopital Henri MONDOR
    Créteil, Île-de-France Region, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.